US Stock MarketDetailed Quotes

VERV Verve Therapeutics

Watchlist
  • 5.290
  • +0.440+9.07%
Close Nov 25 16:00 ET
  • 5.170
  • -0.120-2.27%
Post 20:01 ET
447.87MMarket Cap-2150P/E (TTM)

Verve Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
120.24%6.87M
219.73%6.69M
305.63%5.7M
505.77%11.76M
408.30%5.14M
235.52%3.12M
2.09M
1.4M
1.94M
1.01M
Operating revenue
120.24%6.87M
219.73%6.69M
305.63%5.7M
505.77%11.76M
408.30%5.14M
235.52%3.12M
--2.09M
--1.4M
--1.94M
--1.01M
Cost of revenue
Gross profit
Operating expense
15.01%63.78M
8.00%65.53M
4.82%62.54M
40.12%234.88M
21.28%59.09M
23.80%55.45M
43.81%60.68M
86.88%59.66M
92.53%167.63M
49.73%48.72M
Selling and administrative expenses
18.41%13.84M
8.43%14.55M
12.83%14.16M
33.05%49.94M
7.37%12.28M
21.83%11.69M
47.97%13.42M
68.84%12.55M
98.96%37.53M
73.28%11.44M
-General and administrative expense
18.41%13.84M
8.43%14.55M
12.83%14.16M
33.05%49.94M
7.37%12.28M
21.83%11.69M
47.97%13.42M
68.84%12.55M
98.96%37.53M
73.28%11.44M
Research and development costs
14.10%49.94M
7.88%50.98M
2.69%48.38M
42.16%184.95M
25.55%46.81M
24.34%43.77M
42.67%47.26M
92.36%47.11M
90.75%130.1M
43.74%37.28M
Operating profit
-8.74%-56.91M
-0.44%-58.84M
2.43%-56.84M
-34.67%-223.12M
-13.07%-53.95M
-19.32%-52.33M
-38.85%-58.58M
-82.49%-58.26M
-90.30%-165.69M
-46.62%-47.71M
Net non-operating interest income expense
17.91%6.89M
36.61%7.43M
46.70%8.14M
237.35%23.17M
40.88%6.34M
195.60%5.84M
1,665.58%5.44M
6,663.41%5.55M
4,735.92%6.87M
6,932.81%4.5M
Non-operating interest income
17.91%6.89M
36.61%7.43M
46.70%8.14M
----
----
195.60%5.84M
1,665.58%5.44M
6,663.41%5.55M
----
----
Total other finance cost
----
----
----
-237.35%-23.17M
----
----
----
----
-4,735.92%-6.87M
----
Other net income (expense)
-100.75%-6K
352.42%1.67M
-89.43%78K
-88.90%165K
-132.75%-713K
124.26%802K
-170.58%-662K
-55.99%738K
104.45%1.49M
91.13%2.18M
Other non- operating income (expenses)
-100.75%-6K
352.42%1.67M
-89.43%78K
-88.90%165K
-132.75%-713K
124.26%802K
-170.58%-662K
-55.99%738K
104.45%1.49M
91.13%2.18M
Income before tax
-9.49%-50.03M
7.56%-49.74M
6.44%-48.63M
-26.99%-199.79M
-17.76%-48.32M
-1.11%-45.69M
-31.41%-53.81M
-72.30%-51.98M
-30.77%-157.33M
-30.94%-41.03M
Income tax
55.22%104K
-62.50%66K
106K
418.87%275K
-39.62%32K
67K
176K
0
53K
53K
Net income
-9.56%-50.13M
7.74%-49.81M
6.23%-48.74M
-27.12%-200.07M
-17.69%-48.35M
-1.26%-45.76M
-31.84%-53.98M
-72.30%-51.98M
-30.81%-157.39M
-31.11%-41.09M
Net income continuous Operations
-9.56%-50.13M
7.74%-49.81M
6.23%-48.74M
-27.12%-200.07M
-17.69%-48.35M
-1.26%-45.76M
-31.84%-53.98M
-72.30%-51.98M
-30.81%-157.39M
-31.11%-41.09M
Minority interest income
Net income attributable to the parent company
-9.56%-50.13M
7.74%-49.81M
6.23%-48.74M
-27.12%-200.07M
-17.69%-48.35M
-1.26%-45.76M
-31.84%-53.98M
-72.30%-51.98M
-30.81%-157.39M
-31.11%-41.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-9.56%-50.13M
7.74%-49.81M
6.23%-48.74M
-27.12%-200.07M
-17.69%-48.35M
-1.26%-45.76M
-31.84%-53.98M
-72.30%-51.98M
-30.81%-157.39M
-31.11%-41.09M
Basic earnings per share
18.06%-0.59
32.18%-0.59
29.76%-0.59
-7.22%-3.12
-2.99%-0.69
8.86%-0.72
-3.57%-0.87
-35.48%-0.84
35.04%-2.91
-3.08%-0.67
Diluted earnings per share
18.06%-0.59
32.18%-0.59
29.76%-0.59
-7.22%-3.12
-2.99%-0.69
8.86%-0.72
-3.57%-0.87
-35.48%-0.84
35.04%-2.91
-3.08%-0.67
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 120.24%6.87M219.73%6.69M305.63%5.7M505.77%11.76M408.30%5.14M235.52%3.12M2.09M1.4M1.94M1.01M
Operating revenue 120.24%6.87M219.73%6.69M305.63%5.7M505.77%11.76M408.30%5.14M235.52%3.12M--2.09M--1.4M--1.94M--1.01M
Cost of revenue
Gross profit
Operating expense 15.01%63.78M8.00%65.53M4.82%62.54M40.12%234.88M21.28%59.09M23.80%55.45M43.81%60.68M86.88%59.66M92.53%167.63M49.73%48.72M
Selling and administrative expenses 18.41%13.84M8.43%14.55M12.83%14.16M33.05%49.94M7.37%12.28M21.83%11.69M47.97%13.42M68.84%12.55M98.96%37.53M73.28%11.44M
-General and administrative expense 18.41%13.84M8.43%14.55M12.83%14.16M33.05%49.94M7.37%12.28M21.83%11.69M47.97%13.42M68.84%12.55M98.96%37.53M73.28%11.44M
Research and development costs 14.10%49.94M7.88%50.98M2.69%48.38M42.16%184.95M25.55%46.81M24.34%43.77M42.67%47.26M92.36%47.11M90.75%130.1M43.74%37.28M
Operating profit -8.74%-56.91M-0.44%-58.84M2.43%-56.84M-34.67%-223.12M-13.07%-53.95M-19.32%-52.33M-38.85%-58.58M-82.49%-58.26M-90.30%-165.69M-46.62%-47.71M
Net non-operating interest income expense 17.91%6.89M36.61%7.43M46.70%8.14M237.35%23.17M40.88%6.34M195.60%5.84M1,665.58%5.44M6,663.41%5.55M4,735.92%6.87M6,932.81%4.5M
Non-operating interest income 17.91%6.89M36.61%7.43M46.70%8.14M--------195.60%5.84M1,665.58%5.44M6,663.41%5.55M--------
Total other finance cost -------------237.35%-23.17M-----------------4,735.92%-6.87M----
Other net income (expense) -100.75%-6K352.42%1.67M-89.43%78K-88.90%165K-132.75%-713K124.26%802K-170.58%-662K-55.99%738K104.45%1.49M91.13%2.18M
Other non- operating income (expenses) -100.75%-6K352.42%1.67M-89.43%78K-88.90%165K-132.75%-713K124.26%802K-170.58%-662K-55.99%738K104.45%1.49M91.13%2.18M
Income before tax -9.49%-50.03M7.56%-49.74M6.44%-48.63M-26.99%-199.79M-17.76%-48.32M-1.11%-45.69M-31.41%-53.81M-72.30%-51.98M-30.77%-157.33M-30.94%-41.03M
Income tax 55.22%104K-62.50%66K106K418.87%275K-39.62%32K67K176K053K53K
Net income -9.56%-50.13M7.74%-49.81M6.23%-48.74M-27.12%-200.07M-17.69%-48.35M-1.26%-45.76M-31.84%-53.98M-72.30%-51.98M-30.81%-157.39M-31.11%-41.09M
Net income continuous Operations -9.56%-50.13M7.74%-49.81M6.23%-48.74M-27.12%-200.07M-17.69%-48.35M-1.26%-45.76M-31.84%-53.98M-72.30%-51.98M-30.81%-157.39M-31.11%-41.09M
Minority interest income
Net income attributable to the parent company -9.56%-50.13M7.74%-49.81M6.23%-48.74M-27.12%-200.07M-17.69%-48.35M-1.26%-45.76M-31.84%-53.98M-72.30%-51.98M-30.81%-157.39M-31.11%-41.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -9.56%-50.13M7.74%-49.81M6.23%-48.74M-27.12%-200.07M-17.69%-48.35M-1.26%-45.76M-31.84%-53.98M-72.30%-51.98M-30.81%-157.39M-31.11%-41.09M
Basic earnings per share 18.06%-0.5932.18%-0.5929.76%-0.59-7.22%-3.12-2.99%-0.698.86%-0.72-3.57%-0.87-35.48%-0.8435.04%-2.91-3.08%-0.67
Diluted earnings per share 18.06%-0.5932.18%-0.5929.76%-0.59-7.22%-3.12-2.99%-0.698.86%-0.72-3.57%-0.87-35.48%-0.8435.04%-2.91-3.08%-0.67
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data